The top frequently mutated genes identified in our CRC patients cohort were APC, KRAS, TP53 and MUC4, which were also readily reported in multiple studies (The Cancer Genome Atlas Network, 2012; Abdul et al., 2017; Chang et al., 2019; Mohd Yunos et al., 2019). Here, TP53 is linked to colorectal carcinoma.